Side-by-side comparison of AI visibility scores, market position, and capabilities
Indoor vertical farming company using AI-optimized growing systems. San Francisco, CA. Raised $940M+ including $400M from SoftBank. Partners with Walmart for US farms.
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has raised over $940 million from investors including SoftBank Vision Fund, which invested $200 million in 2017, and has positioned itself as the technology leader in data-driven indoor agriculture.\n\nPlenty's farms use precisely controlled light, temperature, humidity, and nutrient conditions to grow crops that are free from pesticides, use 99% less land, and consume significantly less water than conventional field agriculture. The company's AI systems continuously optimize growing conditions based on sensor data, learning to improve yields and quality across crops and growing cycles.\n\nIn 2022, Plenty announced a landmark partnership with Walmart to supply leafy greens from a new large-scale facility in Compton, California. This partnership provided both a major commercial anchor and significant additional funding from Walmart, validating Plenty's technology and business model at scale. The company also operates a dedicated strawberry R&D partnership with Driscoll's, the world's largest berry company, demonstrating the platform's potential beyond leafy greens.
Science-led synbiotic brand; $56M revenue, profitable, top-5 Amazon probiotic ranking, and expanding into AI-driven microbiome research.
Seed Health is a Los Angeles-based microbial sciences company founded in 2018 by Ara Katz and Raja Dhir. The company is best known for its DS-01 Daily Synbiotic, a two-in-one probiotic and prebiotic capsule developed in partnership with academic researchers. Seed has raised approximately $44 million in total funding, with a Series A led by The Craftory, and has achieved profitability.\n\nThe company reported approximately $56 million in revenue with 500%+ growth over three years, ranking among Amazon's top-five probiotic supplements and selling in Target stores nationwide. Seed differentiates itself by emphasizing clinical research transparency — each strain is backed by published studies, and the brand has become a go-to reference among health-conscious consumers and clinicians.\n\nBeyond consumer products, Seed operates a scientific research arm called SeedLabs that conducts microbiome research in areas including planetary health and pediatric immunity. In 2024, the company announced an AI-powered initiative to accelerate strain discovery. This dual consumer-science identity gives Seed unusual credibility in a supplement category often criticized for weak evidence.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.